Department of Anesthesiology, Second Affiliated Hospital of Mudanjiang Medical University, Mudanjiang, 157000, China.
Department of Pathology, Second Affiliated Hospital of Mudanjiang Medical University, Mudanjiang, 157000, China.
Biomed Pharmacother. 2019 Jan;109:226-232. doi: 10.1016/j.biopha.2018.10.072. Epub 2018 Nov 2.
Osteosarcoma (OS) is the most frequent bone malignancy in human. Growing evidence suggests that circular RNAs (circRNAs) play a significant role in regulating tumorigenesis and progression. Previously, circ_0001721 was identified upregulated in OS tissues screened by circRNA microarrays. In the current study, circ_0001721 expression in OS tissue samples and cells were measured by qRT-PCR. Its clinical value was also explored. For the part of functional assays, CCK-8, clone-forming, flow cytometric, Transwell, xenograft assays were performed. Dual luciferase reporter assays were used to examine the mechanism of circ_0001721. We found that circ_0001721 was enhanced in OS tissue samples and cell lines and the overexpression of circ_0001721 is closely related to clinical severity. In addition, circ_0001721 may be used as a prognostic indicator for OS patients. What's more, loss-of-function and gain-of-function assays demonstrated circ_0001721 facilitates cell progression in OS. Circ_0001721 could sponge miR-569 and miR-599. The oncogenic properties of circ_0001721 is partly attributed to its repression on miR-569 and miR-599. Collectively, the present data reveal the participation of circ_0001721 in tumorigenesis of OS cells, and may indicate a novel therapeutic target.
骨肉瘤(OS)是人类最常见的骨恶性肿瘤。越来越多的证据表明,环状 RNA(circRNA)在调节肿瘤发生和进展方面发挥着重要作用。先前,通过 circRNA 微阵列筛选发现,circ_0001721 在 OS 组织中上调。在本研究中,通过 qRT-PCR 测量了 OS 组织样本和细胞中 circ_0001721 的表达。还探讨了其临床价值。对于功能测定部分,进行了 CCK-8、克隆形成、流式细胞术、Transwell、异种移植测定。双荧光素酶报告基因测定用于研究 circ_0001721 的机制。我们发现 circ_0001721 在 OS 组织样本和细胞系中增强,并且 circ_0001721 的过表达与临床严重程度密切相关。此外,circ_0001721 可能可用作 OS 患者的预后指标。更重要的是,功能丧失和功能获得测定表明 circ_0001721 促进了 OS 中的细胞进展。circ_0001721 可以海绵化 miR-569 和 miR-599。circ_0001721 的致癌特性部分归因于其对 miR-569 和 miR-599 的抑制作用。总之,这些数据揭示了 circ_0001721 在 OS 细胞发生肿瘤中的参与,并可能表明了一种新的治疗靶标。